We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRUS:NASDAQKura Sushi USA, Inc. Analysis

Data as of 2026-04-13 - not real-time

$55.66

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Kura Sushi USA (KRUS) is trading at $55.66, well beneath its 20‑day, 50‑day and 200‑day simple moving averages of $63.0, $66.3 and $67.2, signaling a clear bearish price trend. The 14‑day RSI sits at 38, edging toward oversold territory but not yet indicating a reversal. MACD remains in a bearish configuration, with the line at –1.22 below the signal at –0.18 and a negative histogram, reinforcing downside momentum. Volatility is extreme, with a 30‑day standard deviation of roughly 86% and a beta above 1, suggesting the stock will move sharply on new information. On the fundamentals side, revenue grew 23% year‑over‑year to $307 M, yet gross margin is only 16% and the company posted a net loss of $0.15 per share. Debt is high, with a debt‑to‑equity ratio near 89% and total liabilities outstripping cash on hand.
Operating cash flow is positive at $24 M, but free cash flow is deeply negative (‑$36 M), highlighting cash‑generation pressure. The discounted cash‑flow model values the business at $35.7 per share, implying a downside of roughly 43% from the current price. Analysts remain optimistic, assigning a “buy” consensus and a median price target near $80, but the market sentiment index is in “Extreme Greed” territory, which may be inflating the price. Recent material news showed a 15.7% intraday drop after the company issued a conservative full‑year outlook and announced a CFO transition, despite a Q2 earnings beat. The combination of high leverage, negative profitability, and bearish technical signals makes the near‑term outlook risky. However, the strong revenue growth and positive operating cash flow provide a foundation for a potential turnaround if margins improve and debt is reduced.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Conservative guidance and CFO turnover depress sentiment
  • Price below all major moving averages and bearish MACD
  • High volatility and downside relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Revenue growth of >20% and positive operating cash flow
  • Analyst consensus remains bullish with $80 price target
  • Debt reduction and margin improvement needed but plausible

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential for operational turnaround and cash‑flow conversion
  • Persistent high leverage and negative free cash flow limit upside
  • Valuation still above DCF, requiring significant earnings improvement

Key Metrics & Analysis

Financial Health

Revenue Growth23.30%
Profit Margin-0.63%
P/E Ratio196.1
ROE-0.85%
ROA-0.42%
Debt/Equity88.79
P/B Ratio2.9
Op. Cash Flow$24.2M
Free Cash Flow$-36375124

Technical Analysis

TrendBearish
RSI37.8
Support$53.58
Resistance$74.81
MA 20$63.04
MA 50$66.34
MA 200$67.25
MACDBearish
VolumeIncreasing
Fear & Greed Index87.29

Valuation

Fair Value$35.67
Target Price$79.90
Upside/Downside43.55%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.12
Volatility85.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.